REFERENCES
- Kimura K, Tabei K, Asano Y, Hosoda S. Cardiac arrhythmias in hemodialysis patients. A study of incidence and contributory factors. Nephron. 1989;53:201–207.
- Yetkin E, Ileri M, Tandogan I, . Increased QT interval dispersion after hemodialysis: Role of peridialytic electrolyte gradients. Angiology. 2000;51:499–504.
- Huijgen HJ, Sanders R, van Olden RW, Klous MG, Gaffar FR, Sanders GT. Intracellular and extracellular blood magnesium fractions in hemodialysis patients; is the ionized fraction a measure of magnesium excess? Clin Chem. 1998;44:639–648.
- Navarro-Gonzalez JF. Magnesium in dialysis patients: Serum levels and clinical implications. Clin Nephrol. 1998;49:373–378.
- Paskalev E, Genova M. Free magnesium in patients on regular dialysis treatment. Nephron. 1999;81:356–357.
- Pedrozzi NE, Truttmann AC, Faraone R, . Circulating ionized and total magnesium in end-stage kidney disease. Nephron. 1998;79:288–292.
- Averbukh Z, Rosenberg R, Galperin E, . Cell-associated magnesium and QT dispersion in hemodialysis patients. Am J Kidney Dis. 2003;41:196–202.
- Elsharkawy MM, Youssef AM, Zayoon MY. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates. Hemodial Int. 2006;10(Suppl. 2):S16–S23.
- Kelber J, Slatopolsky E, Delmez JA. Acute effects of different concentrations of dialysate magnesium during high-efficiency dialysis. Am J Kidney Dis. 1994;24:453–460.
- Kyriazis J, Pikounis V, Smirnioudis N. Use of the QTc interval and QTc dispersion in patients on hemodialysis: Assessment of reproducibility. Nephrol Dial Transplant. 2004;19:516–517.
- Howse M, Sastry S, Bell GM. Changes in the corrected QT interval and corrected QT dispersion during hemodialysis. Postgrad Med J. 2002;78:273–275.
- Yildiz A, Akkaya V, Tukek T, . Increased QT dispersion in hemodialysis patients improve after renal transplantation: A prospective-controlled study. Transplantation. 2001;72:1523–1526.
- Yildiz A, Akkaya V, Sahin S, . QT dispersion and signal-averaged electrocardiogram in hemodialysis and CAPD patients. Perit Dial Int. 2001;21:186–192.
- Lorincz I, Matyus J, Zilahi Z, Kun C, Karanyi Z, Kakuk G. QT dispersion in patients with end-stage renal failure and during hemodialysis. J Am Soc Nephrol. 1999;10:1297–1302.
- Covic A, Diaconita M, Gusbeth-Tatomir P, . Hemodialysis increases QT(c) interval but not QT(c) dispersion in ESRD patients without manifest cardiac disease. Nephrol Dial Transplant. 2002;17:2170–2177.
- Gussak I, Gussak HM. Sudden cardiac death in nephrology: Focus on acquired long QT syndrome. Nephrol Dial Transplant. 2007;22:12–14.
- Selby NM, McIntyre CW. The acute cardiac effects of dialysis. Semin Dial. 2007;20:220–228.
- Morris ST, Galiatsou E, Stewart GA, Rodger RS, Jardine AG. QT dispersion before and after hemodialysis. J Am Soc Nephrol. 1999;10:160–163.
- Beaubien ER, Pylypchuk GB, Akhtar J, Biem HJ. Value of corrected QT interval dispersion in identifying patients initiating dialysis at increased risk of total and cardiovascular mortality. Am J Kidney Dis. 2002;39:834–842.
- Locsey L, Szlanka B, Menes I, . The importance of bioimpedance (BIA) analysis and Cardio Tens (24-h ABPM and ECG) monitoring in the dialysis programme. Int Urol Nephrol. 1999;31:547–555.
- Grushka E, Garty J, Kristal B, Goldhammer E, Abineder EG, Shasha SM. Cardiac arrhythmia in chronic renal failure: Holter monitoring during hemodialysis and intermittent peritoneal dialysis. Isr J Med Sci. 1990;26:378–382.
- Wander GS, Sandha GS, Chhabra SC, Khaira NS, Chinna RS. Holter monitoring in chronic renal failure before & during dialysis. J Assoc Physicians India. 1994;42:290–293.
- Kyriazis J, Kalogeropoulou K, Bilirakis L, . Dialysate magnesium level and blood pressure. Kidney Int. 2004;66:1221–1231.
- Cupisti A, Galetta F, Caprioli R, . Potassium removal increases the QTc interval dispersion during hemodialysis. Nephron. 1999;82:122–126.
- Nappi SE, Virtanen VK, Saha HH, Mustonen JT, Pasternack AI. QTc dispersion increases during hemodialysis with low-calcium dialysate. Kidney Int. 2000;57:2117–2122.
- Sicouri S, Antzelevitch D, Heilmann C, Antzelevitch C. Effects of sodium channel block with mexiletine to reverse action potential prolongation in in vitro models of the long term QT syndrome. J Cardiovasc Electrophysiol. 1997;8:1280–1290.
- Shimizu W, Antzelevitch C. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome. Circulation. 1997;96:2038–2047.